肺炎診断の世界市場

【英語タイトル】Pneumonia Diagnostic - Global Market Outlook (2016-2022)

Stratistics MRCが出版した調査資料(SMRC70523081)・商品コード:SMRC70523081
・発行会社(調査会社):Stratistics MRC
・発行日:2017年3月
・ページ数:152
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、肺炎診断の世界市場について調査・分析し、肺炎診断の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- 肺炎診断の世界市場:市場動向分析
- 肺炎診断の世界市場:競争要因分析
- 肺炎診断の世界市場:治療別
・ワクチン
・抗生物質
- 肺炎診断の世界市場:検査別
・血液検査
・気管支鏡検査法
・胸部X線
・胸部コンピューター断層撮影(CT)スキャン
・パルスオキシメトリ
・胸水培養
・喀痰検査
- 肺炎診断の世界市場:エンドユーザー別
・クリニック
・診断センター
・病院
・民間/私立研究所
・その他
- 肺炎診断の世界市場:主要地域別分析
- 肺炎診断の北米市場規模(アメリカ市場等)
- 肺炎診断のヨーロッパ市場規模
- 肺炎診断のアジア市場規模(日本市場、中国市場、インド市場等)
・肺炎診断の世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the global Pneumonia Diagnostic market is accounted for $xx million in 2016 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2016 to 2022. Factors such as developing innovative technologies and products, increasing patient awareness and improving productivity of diagnosing pneumonia are boosting the market growth. Advent of new drugs and advance treatment facilitates are going to provide new market opportunities to emerge. However, there is no particular treatment available to detect the pneumonia as its symptoms coincide with diseases like bronchitis, common cold and asthma which are restraining the market growth.

Chest X-ray and CT scan are generally recommended for the diagnosis of pneumonia diagnostics. North America is the largest market due to increasing resistance to multi drugs by microorganisms and increasing geriatric population. Asia Pacific is anticipated to be the fastest growing market owing to prevalence of disease in several countries including India, Japan and Bangladesh. Additionally, high awareness and disposable income are potential growth factors.

Some of the key players in global Pneumonia Diagnostic market are Abbott, Affymetrix, Beckman Coulter Inc, Becton Dickinson, BioMerieux, Bio-Rad, Cepheid, Diamedix, Elitech Group, Qiagen, Siemens, Thermo Fisher Scientific, GlaxoSmithCline and Merck & Co.
Treatments Covered:
• Vaccines
o PCV13
o PPV23
• Antibiotics
o Amoxicillin
o Cephalosporin
o Penicillin
o Tetracycline
o Vancomycin
o Fluoroquinolones

Tests Covered:
• Blood Test
• Bronchoscopy
• Chest X ray
• Chest Computed Tomography (CT) Scan
• Pulse Oximetry
• Pleural Fluid Culture
• Sputum Test
End Users Covered:
• Clinics
• Diagnostic Centres
• Hospitals
• Commercial/Private Labs
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pneumonia Diagnostic Market, By Treatment
5.1 Introduction
5.2 Vaccines
5.2.1 PCV13
5.2.2 PPV23
5.3 Antibiotics
5.3.1 Amoxicillin
5.3.2 Cephalosporin
5.3.3 Penicillin
5.3.4 Tetracycline
5.3.5 Vancomycin
5.3.6 Fluoroquinolones

6 Global Pneumonia Diagnostic Market, By Test
6.1 Introduction
6.2 Blood Test
6.3 Bronchoscopy
6.4 Chest X ray
6.5 Chest Computed Tomography (CT) Scan
6.6 Pulse Oximetry
6.7 Pleural Fluid Culture
6.8 Sputum Test

7 Global Pneumonia Diagnostic Market, By End User
7.1 Introduction
7.2 Clinics
7.3 Diagnostic Centres
7.4 Hospitals
7.5 Commercial/Private Labs
7.6 Other End Users

8 Global Pneumonia Diagnostic Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Abbott
10.2 Affymetrix
10.3 Beckman Coulter Inc
10.4 Becton Dickinson
10.5 bioMerieux
10.6 Bio-Rad
10.7 Cepheid
10.8 Diamedix
10.9 Elitech Group
10.10 Qiagen
10.11 Siemens
10.12 Thermo Fisher Scientific
10.13 GlaxoSmithCline
10.14 Merck & Co

List of Tables
Table 1 Global Pneumonia Diagnostic Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 3 Global Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 4 Global Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 5 Global Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 6 Global Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 7 Global Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 8 Global Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 9 Global Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 10 Global Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 11 Global Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 12 Global Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 13 Global Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 14 Global Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 15 Global Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 16 Global Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 17 Global Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 18 Global Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 19 Global Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 20 Global Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 21 Global Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 22 Global Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 23 Global Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 24 Global Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 25 Global Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 26 Global Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
Table 27 North America Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
Table 28 North America Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 29 North America Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 30 North America Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 31 North America Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 32 North America Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 33 North America Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 34 North America Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 35 North America Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 36 North America Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 37 North America Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 38 North America Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 39 North America Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 40 North America Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 41 North America Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 42 North America Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 43 North America Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 44 North America Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 45 North America Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 46 North America Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 47 North America Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 48 North America Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 49 North America Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 50 North America Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 51 North America Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 52 North America Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
Table 53 Europe Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
Table 54 Europe Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 55 Europe Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 56 Europe Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 57 Europe Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 58 Europe Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 59 Europe Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 60 Europe Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 61 Europe Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 62 Europe Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 63 Europe Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 64 Europe Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 65 Europe Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 66 Europe Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 67 Europe Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 68 Europe Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 69 Europe Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 70 Europe Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 71 Europe Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 72 Europe Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 73 Europe Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 74 Europe Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 75 Europe Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 76 Europe Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 77 Europe Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 78 Europe Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
Table 79 Asia Pacific Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
Table 80 Asia Pacific Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 81 Asia Pacific Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 82 Asia Pacific Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 83 Asia Pacific Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 84 Asia Pacific Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 85 Asia Pacific Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 86 Asia Pacific Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 87 Asia Pacific Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 88 Asia Pacific Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 89 Asia Pacific Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 90 Asia Pacific Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 91 Asia Pacific Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 92 Asia Pacific Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 93 Asia Pacific Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 94 Asia Pacific Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 95 Asia Pacific Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 96 Asia Pacific Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 97 Asia Pacific Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 98 Asia Pacific Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 99 Asia Pacific Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 100 Asia Pacific Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 101 Asia Pacific Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 102 Asia Pacific Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 103 Asia Pacific Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 104 Asia Pacific Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
Table 105 RoW Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
Table 106 RoW Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 107 RoW Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 108 RoW Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 109 RoW Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 110 RoW Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 111 RoW Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 112 RoW Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 113 RoW Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 114 RoW Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 115 RoW Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 116 RoW Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 117 RoW Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 118 RoW Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 119 RoW Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 120 RoW Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 121 RoW Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 122 RoW Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 123 RoW Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 124 RoW Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 125 RoW Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 126 RoW Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 127 RoW Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 128 RoW Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 129 RoW Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 130 RoW Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)



★調査レポート[肺炎診断の世界市場] (コード:SMRC70523081)販売に関する免責事項を必ずご確認ください。
★調査レポート[肺炎診断の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆